Ascorbyl palmitate, sodium ascorbyl phosphate and magnesium ascorbyl phosphate are derivatives of ascorbic acid which differ in hydrolipophilic properties. They are widely used in cosmetic and pharmaceutical preparations.
Highlights
The global Vitamin C Derivatives market was valued at US$ 1249 million in 2022 and is anticipated to reach US$ 1737.9 million by 2029, witnessing a CAGR of 4.9% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global main players in vitamin C derivatives industry are DSM, MacroCare Tech and CSPC Pharma.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vitamin C Derivatives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vitamin C Derivatives.
The Vitamin C Derivatives market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Vitamin C Derivatives market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vitamin C Derivatives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
DSM
MacroCare Tech
CSPC Pharma
Shandong Luwei
Northeast Pharma
North China Pharma
Shandong Tianli
Ningxia Qiyuan
Zhengzhou Tuoyang
Anhui Tiger
Jingjiang Hengtong Bio- Engineering
Segment by Type
Food Grade
Pharmaceutical Grade
Feed Grade
Segment by Application
Food & Beverage
Pharmaceuticals & Healthcare
Personal Care & Cosmetics
Feed
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vitamin C Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Vitamin C Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Vitamin C Derivatives 麻豆原创 Overview
1.1 Product Overview and Scope of Vitamin C Derivatives
1.2 Vitamin C Derivatives Segment by Type
1.2.1 Global Vitamin C Derivatives 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Food Grade
1.2.3 Pharmaceutical Grade
1.2.4 Feed Grade
1.3 Vitamin C Derivatives Segment by Application
1.3.1 Global Vitamin C Derivatives 麻豆原创 Value by Application: (2023-2029)
1.3.2 Food & Beverage
1.3.3 Pharmaceuticals & Healthcare
1.3.4 Personal Care & Cosmetics
1.3.5 Feed
1.4 Global Vitamin C Derivatives 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Vitamin C Derivatives Revenue 2018-2029
1.4.2 Global Vitamin C Derivatives Sales 2018-2029
1.4.3 Global Vitamin C Derivatives 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vitamin C Derivatives 麻豆原创 Competition by Manufacturers
2.1 Global Vitamin C Derivatives Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Vitamin C Derivatives Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Vitamin C Derivatives Average Price by Manufacturers (2018-2023)
2.4 Global Vitamin C Derivatives Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Vitamin C Derivatives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vitamin C Derivatives, Product Type & Application
2.7 Vitamin C Derivatives 麻豆原创 Competitive Situation and Trends
2.7.1 Vitamin C Derivatives 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vitamin C Derivatives Players 麻豆原创 Share by Revenue
2.7.3 Global Vitamin C Derivatives 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vitamin C Derivatives Retrospective 麻豆原创 Scenario by Region
3.1 Global Vitamin C Derivatives 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vitamin C Derivatives Global Vitamin C Derivatives Sales by Region: 2018-2029
3.2.1 Global Vitamin C Derivatives Sales by Region: 2018-2023
3.2.2 Global Vitamin C Derivatives Sales by Region: 2024-2029
3.3 Global Vitamin C Derivatives Global Vitamin C Derivatives Revenue by Region: 2018-2029
3.3.1 Global Vitamin C Derivatives Revenue by Region: 2018-2023
3.3.2 Global Vitamin C Derivatives Revenue by Region: 2024-2029
3.4 North America Vitamin C Derivatives 麻豆原创 Facts & Figures by Country
3.4.1 North America Vitamin C Derivatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vitamin C Derivatives Sales by Country (2018-2029)
3.4.3 North America Vitamin C Derivatives Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Vitamin C Derivatives 麻豆原创 Facts & Figures by Country
3.5.1 Europe Vitamin C Derivatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vitamin C Derivatives Sales by Country (2018-2029)
3.5.3 Europe Vitamin C Derivatives Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vitamin C Derivatives 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Vitamin C Derivatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vitamin C Derivatives Sales by Country (2018-2029)
3.6.3 Asia Pacific Vitamin C Derivatives Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Vitamin C Derivatives 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Vitamin C Derivatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vitamin C Derivatives Sales by Country (2018-2029)
3.7.3 Latin America Vitamin C Derivatives Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vitamin C Derivatives 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Vitamin C Derivatives 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vitamin C Derivatives Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vitamin C Derivatives Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Vitamin C Derivatives Sales by Type (2018-2029)
4.1.1 Global Vitamin C Derivatives Sales by Type (2018-2023)
4.1.2 Global Vitamin C Derivatives Sales by Type (2024-2029)
4.1.3 Global Vitamin C Derivatives Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Vitamin C Derivatives Revenue by Type (2018-2029)
4.2.1 Global Vitamin C Derivatives Revenue by Type (2018-2023)
4.2.2 Global Vitamin C Derivatives Revenue by Type (2024-2029)
4.2.3 Global Vitamin C Derivatives Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Vitamin C Derivatives Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vitamin C Derivatives Sales by Application (2018-2029)
5.1.1 Global Vitamin C Derivatives Sales by Application (2018-2023)
5.1.2 Global Vitamin C Derivatives Sales by Application (2024-2029)
5.1.3 Global Vitamin C Derivatives Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Vitamin C Derivatives Revenue by Application (2018-2029)
5.2.1 Global Vitamin C Derivatives Revenue by Application (2018-2023)
5.2.2 Global Vitamin C Derivatives Revenue by Application (2024-2029)
5.2.3 Global Vitamin C Derivatives Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Vitamin C Derivatives Price by Application (2018-2029)
6 Key Companies Profiled
6.1 DSM
6.1.1 DSM Corporation Information
6.1.2 DSM Description and Business Overview
6.1.3 DSM Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.1.4 DSM Vitamin C Derivatives Product Portfolio
6.1.5 DSM Recent Developments/Updates
6.2 MacroCare Tech
6.2.1 MacroCare Tech Corporation Information
6.2.2 MacroCare Tech Description and Business Overview
6.2.3 MacroCare Tech Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.2.4 MacroCare Tech Vitamin C Derivatives Product Portfolio
6.2.5 MacroCare Tech Recent Developments/Updates
6.3 CSPC Pharma
6.3.1 CSPC Pharma Corporation Information
6.3.2 CSPC Pharma Description and Business Overview
6.3.3 CSPC Pharma Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CSPC Pharma Vitamin C Derivatives Product Portfolio
6.3.5 CSPC Pharma Recent Developments/Updates
6.4 Shandong Luwei
6.4.1 Shandong Luwei Corporation Information
6.4.2 Shandong Luwei Description and Business Overview
6.4.3 Shandong Luwei Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shandong Luwei Vitamin C Derivatives Product Portfolio
6.4.5 Shandong Luwei Recent Developments/Updates
6.5 Northeast Pharma
6.5.1 Northeast Pharma Corporation Information
6.5.2 Northeast Pharma Description and Business Overview
6.5.3 Northeast Pharma Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Northeast Pharma Vitamin C Derivatives Product Portfolio
6.5.5 Northeast Pharma Recent Developments/Updates
6.6 North China Pharma
6.6.1 North China Pharma Corporation Information
6.6.2 North China Pharma Description and Business Overview
6.6.3 North China Pharma Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.6.4 North China Pharma Vitamin C Derivatives Product Portfolio
6.6.5 North China Pharma Recent Developments/Updates
6.7 Shandong Tianli
6.6.1 Shandong Tianli Corporation Information
6.6.2 Shandong Tianli Description and Business Overview
6.6.3 Shandong Tianli Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shandong Tianli Vitamin C Derivatives Product Portfolio
6.7.5 Shandong Tianli Recent Developments/Updates
6.8 Ningxia Qiyuan
6.8.1 Ningxia Qiyuan Corporation Information
6.8.2 Ningxia Qiyuan Description and Business Overview
6.8.3 Ningxia Qiyuan Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ningxia Qiyuan Vitamin C Derivatives Product Portfolio
6.8.5 Ningxia Qiyuan Recent Developments/Updates
6.9 Zhengzhou Tuoyang
6.9.1 Zhengzhou Tuoyang Corporation Information
6.9.2 Zhengzhou Tuoyang Description and Business Overview
6.9.3 Zhengzhou Tuoyang Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Zhengzhou Tuoyang Vitamin C Derivatives Product Portfolio
6.9.5 Zhengzhou Tuoyang Recent Developments/Updates
6.10 Anhui Tiger
6.10.1 Anhui Tiger Corporation Information
6.10.2 Anhui Tiger Description and Business Overview
6.10.3 Anhui Tiger Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Anhui Tiger Vitamin C Derivatives Product Portfolio
6.10.5 Anhui Tiger Recent Developments/Updates
6.11 Jingjiang Hengtong Bio- Engineering
6.11.1 Jingjiang Hengtong Bio- Engineering Corporation Information
6.11.2 Jingjiang Hengtong Bio- Engineering Vitamin C Derivatives Description and Business Overview
6.11.3 Jingjiang Hengtong Bio- Engineering Vitamin C Derivatives Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Jingjiang Hengtong Bio- Engineering Vitamin C Derivatives Product Portfolio
6.11.5 Jingjiang Hengtong Bio- Engineering Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vitamin C Derivatives Industry Chain Analysis
7.2 Vitamin C Derivatives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vitamin C Derivatives Production Mode & Process
7.4 Vitamin C Derivatives Sales and 麻豆原创ing
7.4.1 Vitamin C Derivatives Sales Channels
7.4.2 Vitamin C Derivatives Distributors
7.5 Vitamin C Derivatives Customers
8 Vitamin C Derivatives 麻豆原创 Dynamics
8.1 Vitamin C Derivatives Industry Trends
8.2 Vitamin C Derivatives 麻豆原创 Drivers
8.3 Vitamin C Derivatives 麻豆原创 Challenges
8.4 Vitamin C Derivatives 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
DSM
MacroCare Tech
CSPC Pharma
Shandong Luwei
Northeast Pharma
North China Pharma
Shandong Tianli
Ningxia Qiyuan
Zhengzhou Tuoyang
Anhui Tiger
Jingjiang Hengtong Bio- Engineering
听
听
*If Applicable.